Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I et al (2009) Assessment of beta-amyloid deposits in human brain: A study of the BrainNet Europe Consortium. Acta Neuropathol 117:309–320. https://doi.org/10.1007/s00401-009-0485-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD et al (2024) Down Syndrome Biobank Consortium: A perspective. Alzheimers Dement 20:2262–2272. https://doi.org/10.1002/alz.13692

Article  PubMed  PubMed Central  Google Scholar 

Arboleda-Velasquez JF, Lopera F, O’Hare M, Delgado-Tirado S, Marino C, Chmielewska N et al (2019) Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: A case report. Nat Med 25:1680–1683. https://doi.org/10.1038/s41591-019-0611-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: A cross-sectional study. Lancet Neurol 15:934–943. https://doi.org/10.1016/S1474-4422(16)30029-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: A multi-centre study. Acta Neuropathol 141:159–172. https://doi.org/10.1007/s00401-020-02255-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A (1997) Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 41(Pt 2):152–164. https://doi.org/10.1111/j.1365-2788.1997.tb00692.x

Article  PubMed  Google Scholar 

Baiardi S, Hansson O, Levin J, Parchi P (2024) In vivo detection of Alzheimer’s and Lewy body disease concurrence: Clinical implications and future perspectives. Alzheimers Dement 20:5757–5770. https://doi.org/10.1002/alz.14039

Article  PubMed  PubMed Central  Google Scholar 

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS (2025) Current advances and unmet needs in Alzheimer’s disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers. Alzheimers Dement 21:e70258. https://doi.org/10.1002/alz.70258

Article  PubMed  PubMed Central  Google Scholar 

Beach TG, Sue LI, Scott S, Intorcia AJ, Walker JE, Arce RA et al (2023) Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy. J Neuropathol Exp Neurol 82:457–466. https://doi.org/10.1093/jnen/nlad026

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R et al (2007) Circle of Willis atherosclerosis: Association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 113:13–21. https://doi.org/10.1007/s00401-006-0136-y

Article  PubMed  Google Scholar 

Becker L, Mito T, Takashima S, Onodera K (1991) Growth and development of the brain in Down syndrome. Prog Clin Biol Res 373:133–152

CAS  PubMed  Google Scholar 

Bernhardt AM, Rodriguez-Baz I, Aldecoa I, Arranz J, Arriola-Infante JE, Maure-Blesa L et al (2025) Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer’s disease. Alzheimers Dement 21:e70342. https://doi.org/10.1002/alz.70342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bodhireddy S, Dickson DW, Mattiace L, Weidenheim KM (1994) A case of Down’s syndrome with diffuse Lewy body disease and Alzheimer’s disease. Neurology 44:159–161. https://doi.org/10.1212/wnl.44.1.159

Article  CAS  PubMed  Google Scholar 

Boyle R, Koops EA, Ances B, Andrews EJ, Arenaza-Urquijo EM, Benjanin A et al (2025) Resistance and resilience to Alzheimer’s disease in Down syndrome. Alzheimers Dement 21:e70151. https://doi.org/10.1002/alz.70151

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259. https://doi.org/10.1007/BF00308809

Article  CAS  PubMed  Google Scholar 

Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171–181. https://doi.org/10.1007/s00401-010-0789-4

Article  PubMed  Google Scholar 

Buehner BJ, Morcillo-Nieto AO, Zsadanyi SE, Rozalem Aranha M, Arriola-Infante JE, Vaque-Alcazar L et al (2025) Medial temporal lobe atrophy in Down syndrome along the Alzheimer’s disease continuum. Brain 148:2509–2521. https://doi.org/10.1093/brain/awaf133

Article  PubMed  PubMed Central  Google Scholar 

Burt DB, Aylward EH (2000) Test battery for the diagnosis of dementia in individuals with intellectual disability. Working Group for the Establishment of Criteria for the Diagnosis of Dementia in Individuals with Intellectual Disability. J Intellect Disabil Res 44(Pt 2):175–180. https://doi.org/10.1046/j.1365-2788.2000.00264.x

Article  PubMed  Google Scholar 

Canan F, Wick N, Raisanen JM, Burns DK, Hatanpaa KJ, Richardson TE et al (2025) Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome. J Alzheimers Dis. https://doi.org/10.1177/13872877251362762

Article  PubMed  PubMed Central  Google Scholar 

Carmona-Iragui M, Balasa M, Benejam B, Alcolea D, Fernandez S, Videla L et al (2017) Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer’s disease. Alzheimers Dement 13:1251–1260. https://doi.org/10.1016/j.jalz.2017.03.007

Article  PubMed  PubMed Central  Google Scholar 

Carmona-Iragui M, Videla L, Lleo A, Fortea J (2019) Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: the complex triangle of brain amyloidosis. Dev Neurobiol 79:716–737. https://doi.org/10.1002/dneu.22709

Article  PubMed  Google Scholar 

Coyle JT, Oster-Granite ML, Gearhart JD (1986) The neurobiologic consequences of Down syndrome. Brain Res Bull 16:773–787. https://doi.org/10.1016/0361-9230(86)90074-2

Article  CAS  PubMed  Google Scholar 

Dahl MJ, Kulesza A, Werkle-Bergner M, Mather M (2023) Declining locus coeruleus-dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer’s disease. Neurosci Biobehav Rev 153:105358. https://doi.org/10.1016/j.neubiorev.2023.105358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S et al (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703–713. https://doi.org/10.1007/s00401-011-0879-y

Article  PubMed  Google Scholar 

Davidson YS, Robinson A, Prasher VP, Mann DMA (2018) The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome. Acta Neuropathol Commun 6:56. https://doi.org/10.1186/s40478-018-0559-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeCarli C, Maillard P, Pase MP, Beiser AS, Kojis D, Satizabal CL et al (2024) Trends in intracranial and cerebral volumes of Framingham Heart Study participants born 1930 to 1970. JAMA Neurol 81:471–480. https://doi.org/10.1001/jamaneurol.2024.0469

Article  PubMed  PubMed Central  Google Scholar 

Dimopoulos K, Constantine A, Clift P, Condliffe R, Moledina S, Jansen K et al (2023) Cardiovascular complications of Down syndrome: scoping review and expert consensus. Circulation 147:425–441. https://doi.org/10.1161/CIRCULATIONAHA.122.059706

Article  CAS  PubMed